Why the study?
What factors influence the prescription of warfarin for stroke prophylaxis in patients with nonvalvular atrial fibrillation?
What factors influence the prescription of warfarin for stroke prophylaxis in patients with nonvalvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
There are significant racial and physician-specialty disparities in the prescription of warfarin for stroke prophylaxis in nonvalvular atrial fibrillation, highlighting a lack of uniform guideline adherence.
OBJECTIVES: Despite evidence supporting anticoagulant use in atrial fibrillation, this modality is not fully utilized. METHODS: Retrospective chart review of 297 patients with nonvalvular atrial fibrillation between 1997 to 2000. 124 patients received warfarin and 166 did not; 91 patients suffered stroke. RESULTS: Age (P = 0.232) and gender (P = 0.745) were not determinant factors for starting anticoagulation prophylaxis. Whites were more likely to receive anticoagulation therapy than blacks (P = 0.043). Cardiologists were 4.5 times more likely to prescribe warfarin than neurologists and internists (P = 0.035). Neurologists (P = 0.305) and internists (P = 0.770) had similar warfarin prescription patterns and often with patients experiencing the highest rates of stroke. CONCLUSION: Lack of a uniform pattern in anticoagulant administration, despite multiple guidelines, is disturbing. Continuous physician education and community awareness by local and federal medical agencies is essential and cost-effective.
No takes yet. Share an insight, caveat, or question.
Rahimi et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: